• FirefoxUpgrade to the new Firefox »
  •  Dow Down1.45% Nasdaq Down1.03%

    Valeant Pharmaceuticals International, Inc. (VRX)

    159.97 Down 1.54(0.95%) Jan 30, 4:01PM EST
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Net Income (866,142) (116,025) 159,559  
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation2,105,267  1,022,624  639,706  
    Adjustments To Net Income178,650  3,257  (21,673)
    Changes In Accounts Receivables(261,380)(219,431)(164,581)
    Changes In Liabilities(76,548)(8,370)42,067  
    Changes In Inventories(122,701)(80,304)(11,521)
    Changes In Other Operating Activities82,338  54,827  (3,084)
    Total Cash Flow From Operating Activities 1,041,957   656,578   640,473  
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(115,319)(107,638)(58,515)
    Investments17,020  617,574  5,552  
    Other Cash flows from Investing Activities(5,282,087)(3,475,657)(2,755,545)
    Total Cash Flows From Investing Activities (5,380,386) (2,965,721) (2,808,508)
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid(2,101) -   -  
    Sale Purchase of Stock2,261,822  (257,698)(650,003)
    Net Borrowings2,067,410  3,470,677  2,770,687  
    Other Cash Flows from Financing Activities(195,565)(134,999)(158,381)
    Total Cash Flows From Financing Activities 4,027,752   3,057,368   1,948,165  
    Effect Of Exchange Rate Changes(5,074)3,755  (10,288)
    Change In Cash and Cash Equivalents (315,751) 751,980   (230,158)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.